Trial Profile
Phase II trial of TS-1 plus Trastuzumab in patients with metastatic breast cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Nov 2015
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Trastuzumab (Primary)
- Indications Breast cancer
- Focus Adverse reactions; Therapeutic Use
- 22 Dec 2010 New trial record